These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20517591)

  • 1. Recent population changes in HbA(1c) and fasting insulin concentrations among US adults with preserved glucose homeostasis.
    Cheng YJ; Kahn HS; Gregg EW; Imperatore G; Geiss LS
    Diabetologia; 2010 Sep; 53(9):1890-3. PubMed ID: 20517591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study.
    Faerch K; Borch-Johnsen K; Vaag A; Jørgensen T; Witte DR
    Diabetologia; 2010 May; 53(5):858-65. PubMed ID: 20182862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7).
    Heianza Y; Arase Y; Fujihara K; Hsieh SD; Saito K; Tsuji H; Kodama S; Yahagi N; Shimano H; Yamada N; Hara S; Sone H
    Diabetes Care; 2012 May; 35(5):1050-2. PubMed ID: 22456865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
    Inoue K; Matsumoto M; Akimoto K
    Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
    Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
    Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
    Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
    Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Oct; 29(10):1285-90. PubMed ID: 22486679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
    Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
    Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between hemoglobin A 1c and spot glucose measurements in Nigerians with type 2 diabetes mellitus.
    Edo AE; Akhuemokhan K
    Niger J Clin Pract; 2012; 15(1):23-6. PubMed ID: 22437083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
    Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
    Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Luis Bautista J; Bugos C; Dirnberger G; Atherton T
    Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.